Vertex Pharmaceuticals Finance Lease Interest Payment remained flat by 0.0% to $1.40M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 78.2%, from $6.43M to $1.40M. Over 2 years (FY 2023 to FY 2025), Finance Lease Interest Payment shows a downward trend with a -61.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher interest payments relative to total lease payments suggest a higher cost of capital or more expensive lease terms.
The portion of finance lease payments that is classified as interest expense rather than principal reduction. This metri...
Standard for companies with significant capital lease obligations.
glw_finance_lease_interest_payment| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $38.40M | $25.70M | $5.60M |
| YoY Change | — | -33.1% | -78.2% |